The mission of the USC ADRC is to Reduce Alzheimer and Vascular Contributions to Cognitive Impairment in Diverse Populations. Our population cohorts include Caucasians ((Long Beach Longitudinal Study), Latino Americans (Los Angeles Latino Eye Study), and Asian Americans (Chinese American Eye Study). We work closely with other major programs at USC on atherosclerosis, including two program projects (The Aging Brain: Vasculature, H Chui PI;Progesterone in Brain Aging and AD, R Brinton, PI) Our philosophy is to recruit outstanding USC faculty to initiate innovative research that will be successful in garnering external funding. Key strategies include: 1) offering resources through our Cores (e.g., human subjects, tissues, and expertise), 2) annual research conference, and 3) pilot projects. The ADRC comprise 6 Cores (Administration, Data, Clinical, Education, Pathology, and Imaging) and 3 Projects: Zelinski (Course of Cognitive Change in Late Adulthood), Brinton/Pike (Novel NeuroSERMs and NeuroSARMs for protection against Alzheimer pathology), and Zheng (Cognitive Impairment in a Chinese American Community).
The Specific Aims of the Administrative Core are to: 1) Promote basic and clinical research at USC to reduce Alzheimer and vascular contributions to cognitive impairment in diverse populations, 2) Sponsor Joint Research Symposia with the EIT Core, including biannual Finch Symposium, 3) Solicit and select pilot projects consonant with the center them to promote the development of new grants, 4) Actively participate in collaborative and national research initiatives (including NACC, ADCS, ADNI, and GWAS) and resource sharing, 5) Guide appropriate and optimal utilization of Center Resources and Funding, 6) Seek annual oversight/advice from External and Internal Advisory Committees, and 7) Assist in protection of human subjects in research and facilitate submissions to the Institutional Review Board (IRB).
|Schneider, L S; Mangialasche, F; Andreasen, N et al. (2014) Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med 275:251-83|
|Gatto, Nicole M; Henderson, Victor W; Hodis, Howard N et al. (2014) Components of air pollution and cognitive function in middle-aged and older adults in Los Angeles. Neurotoxicology 40:1-7|
|Finch, Caleb E; Beltrán-Sánchez, Hiram; Crimmins, Eileen M (2014) Uneven futures of human lifespans: reckonings from Gompertz mortality rates, climate change, and air pollution. Gerontology 60:183-8|
|Villeneuve, Sylvia; Reed, Bruce R; Wirth, Miranka et al. (2014) Cortical thickness mediates the effect of ?-amyloid on episodic memory. Neurology 82:761-7|
|Porsteinsson, Anton P; Drye, Lea T; Pollock, Bruce G et al. (2014) Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 311:682-91|
|Beecham, Gary W; Hamilton, Kara; Naj, Adam C et al. (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet 10:e1004606|
|Schneider, Lon S (2014) Rethinking the Food and Drug Administration's 2013 guidance on developing drugs for early-stage Alzheimer's disease. Alzheimers Dement 10:247-50|
|Escott-Price, Valentina; Bellenguez, Céline; Wang, Li-San et al. (2014) Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. PLoS One 9:e94661|
|Cuajungco, Math P; Basilio, Luigi C; Silva, Joshua et al. (2014) Cellular zinc levels are modulated by TRPML1-TMEM163 interaction. Traffic 15:1247-65|
|Jayaraman, Anusha; Christensen, Amy; Moser, V Alexandra et al. (2014) Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats. Endocrinology 155:1398-406|
Showing the most recent 10 out of 253 publications